| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2024 | Apr 1, 2024 | Galera Therapeutics, Inc. | Other | Sell | 20.0 | -4,200,000 | -79.55% | ✗ | $811.8K |
| Oct 17, 2018 | Oct 17, 2018 | SOLIGENIX, INC. | Director | Buy | 90.0 | +170,000 | 7.30% | ✗ | $197.2K |